Monday June 26th 2017

Posts Tagged ‘Multiple Sclerosis’

‘Give MS research a chance’

‘Give MS research a chance’

A Wagga woman living with multiple sclerosis has slammed the churches and government for preventing a radical MS treatment from saving lives in Australia. Kerri Bland was diagnosed with MS in 1998. At any moment the disease can aggressively attack her brain leaving her [Read More]

MS sufferer turning to street dealers for drugs

MS sufferer turning to street dealers for drugs

A GRANDMOTHER from Abingdon says she has resorted to buying drugs from street dealers to tackle the pain she suffers from multiple sclerosis. Michelle X – which is her real name – says being cautioned by the police for growing the drug has “changed her life”. And [Read More]

Queensland doctors find therapy to halt progression of M.S.

Queensland doctors find therapy to halt progression of M.S.

BRISBANE researchers believe they have found a way to halt the progression of multiple sclerosis. The world-first experimental therapy has already been tried on wheelchair-bound Queensland dad Gary Allen, who has had “big improvements” since receiving the [Read More]

 Page 1 of 47  1  2  3  4  5 » ...  Last » 

Latest Topics

Are static and functional balance abilities related in individuals with Multiple Sclerosis? – Pau M, Porta M, Coghe G, Corona F, Pilloni G, Lorefice…

Are static and functional balance abilities related in individuals with Multiple Sclerosis? – Pau M, Porta M, Coghe G, Corona F, Pilloni G, Lorefice…

BACKGROUND: In people with Multiple Sclerosis (pwMS), balance assessment is essential in estimating the risk of falls, [Read More]

CHMP Recommends Cladribine (Mavenclad) for Multiple Sclerosis CHMP Recommends Cladribine (Mavenclad) for Multiple Sclerosis

CHMP Recommends Cladribine (Mavenclad) for Multiple Sclerosis CHMP Recommends Cladribine (Mavenclad) for Multiple Sclerosis

The European Medicines Agency ’ s Committee for Medicinal Products for Human Use recommends approval of cladribine to [Read More]

Germany’s Merck gets EU backing for oral MS drug

Germany’s Merck gets EU backing for oral MS drug

FRANKFURT (Reuters) - Germany's Merck KGaA has won a key recommendation to become a late entrant to the market for oral [Read More]

New data at EAN show Roche ’s OCREVUS (ocrelizumab) significantly reduced multiple measures of disease progression in relapsing and primary…

New data at EAN show Roche ’s OCREVUS (ocrelizumab) significantly reduced multiple measures of disease progression in relapsing and primary…

Roche announced today that new post-hoc analyses from the OCREVUS ™ (ocrelizumab) Phase III clinical trial programme [Read More]

MS Society Hosts Joint Congressional Briefing on the Value of Rehabilitation

MS Society Hosts Joint Congressional Briefing on the Value of Rehabilitation

/About-the-Society/News/Society-Hosts-Joint-Congressional-Briefing-on-the [Read More]